We offer access to a world-class HTS screening library containing more than three million well-characterized compounds and a comprehensive data set linked to them.
We screen this library in tailor-made assay setups at high throughput.
Access to world-class, organically grown HTS screening library containing more than three million well-characterized compounds reflecting the long pharma history of Bayer and Schering.
Library subsets for screening are available on request. They include highly diverse and representative subsets for first line screens to tap into the compound universe as well as recently added libraries designed with particular focus on favorable PhysChem properties
The compound library is screened in tailor made assay set up by lead discovery scientists in high throughput at 750.000 data points per day.
Hit follow-up activities performed by Lead Discovery and Life Science Chemistry will yield a condensed hit list which will be handed over to our customer.
The legacy data set is a key resource for our work. Based on a comprehensive data set ranging from physicochemical, biochemical, pharmacological, pharmacokinetic and toxicological data. It contains an enormous data set from more than a decade of in vitro and in vivo research with our compound library ranging from in vitro target testing, analytical chemical assessment to testing in animal models. Digital technologies and data mining allow us to take informed decisions for our partners and clients to design taylor made in vitro and in vivo experiments and work on the most promising chemical matter.